The aim of the present work was to examine possible genetic risk factors related to the occurrence of cerebrovascular disease (CVD) in Brazilian population, the frequency of β S -globin gene haplotypes and co-inheritance with α-thalassemia (-α 3.7kb ) and single nucleotide polymorphism of methylenetetrahydrofolate reductase (MTHFR-C677T), Factor V Leiden (FV-G1691A) and prothrombin (PT-G20210A) genes in children from Rio de Janeiro. Ninety four children with sickle cell anemia (SCA) were included, 24 patients with cerebrovascular involvement and 70 patients without CVD as control group. The mean age of children at the time of the cerebrovascular event was similar to the control group. The frequency of -α 3.7kb thalassemia was similar in both groups (p=0.751). Children with Bantu/Atypical β S -globin gene haplotype presented 15 times more chance (OR=15.4 CI 95% 2.9-81.6) of CVD than the other β S -globin gene haplotypes. The C677T polymorphism of MTHFR gene was similar in both groups (p=0.085). No mutation in the FV Leiden or PT genes was found. A large study seems necessary to establish the role of these genetic polymorphisms in Brazilian miscegenated population. Key words: sickle cell anemia, cerebrovascular disease, alpha-thalassemia, beta-globin haplotypes, genetic polymorphism.
Sickle cell anemia (SCA) is a genetic disorder caused by homozygosity for a single β-globin gene mutation (β 6 GAG→GTG), in which glutamic acid has been substituted for valine at the sixth codon of β-globin chain. Despite this fact, the clinical course of patients suffering from SCA is extremely variable, the severity of manifestations ranging from asymptomatic to a very severe course 1, 2 . The phenotypic variability maybe explained by some genetic factors, those related to globin genes have been well recognized 2 . There is evidence that SCA and other chronic hemolytic anemia are characterized by a hypercoagulable state with increased of thrombin and fibrin generation as well as platelet activation with an augmented risk for thromboembolic complications 3 . Cerebrovascular disease (CVD) is a major complication of sickle cell disease 4 . Stroke is a very severe event and is estimated that approximately 11% of patients will have a clinical stroke by age 20 2, 4 , and 21% have evidence of silent infarction on magnetic resonance imaging 5 . CVD is more frequent among patients with SCA than patients with sickle cell disease, and approximately 10% of children between the ages of 2 to 16 years are at risk for stroke 4, 6 , the incidence is higher in the 1 to 9 years 4 . Anemia, high leukocytes count, high blood pressure and acute chest syndrome are risk factors for the development of CVD in sickle cell disease 2 . A familial predisposition to stroke has been observed, suggesting that genetic factors may contribute to CVD risk 7 . Fetal hemoglobin (HbF) and β S -globin haplotypes are the most studied genetic modulator for SCA, but the diversity of the disease is not completely explained by this modulation, and several potential genetic modifiers have been studied. These candidate genes include mediators of inflammation, vaso-regulation, blood coagulation, haemostasis, growth factors, cytokines and cytokine receptors, and transcriptional factors 8 . Furthermore, the C677T polymorphism in methylenetetrahydrofolate reductase gene as well as Factor V Leiden (FV-G1691A) and prothrombin (PT-G20210A) have been implicated in vascular diseases 8 . Despite the recent studies indicating probable genetic factors, only few have been recognized to influence the risk of stroke in SCA 1 . To examine possible genetic risk factors related to the occurrence of CVD in a group of Brazilian patients, the frequency of β S -globin gene haplotypes and co-inheritance with α-thalassemia (-α 3.7kb ) and single nucleotide polymorphism in methylenetetrahydrofolate reductase (MTHFR-C677T), Factor V Leiden (FV-G1691A) and prothrombin (PT-G20210A) genes were determined in children with SCA followed at the Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti, Rio de Janeiro.
METHOD
After review by local Institutional Ethics Boards and informed consent signed by parent or guardian, blood samples from 94 children with SCA were collected and genomic DNA was extracted from peripheral blood mononuclear cells using a commercial kit (Puregene® DNA Purification System-Gentra). Twenty four children were randomly selected from a cohort of patients that have had CVD, and 70 children were randomly selected from clinic records of the neonatal hemoglobinopathy screening program of the state of Rio de Janeiro, Brazil. The children without CVD were matched by sex and closest in age at the time of the cerebrovascular event to the index cases. 10 . The α-thalassemia (-α 3.7kb ) single gene deletion was detected by PCR, primers were designed to amplify the junction fragments of the α-thalassemia determinants that could be easily identified by size. Since of the -α 3.7kb deletions partially remove both α-genes, the positive amplification was used to indicate heterozygosity when a deleted allele was also present 11 . The C677T mutation in the MTHFR gene, G1691A in FV Leiden and G21210A in prothrombin gene were determined by PCR-RFLP according to the methods described by Frosst et al. 12 , Zöller and Dahlbäck. 13 and Poort et al. 14 , respectively. The MTHFR C677T mutation, primers generate a fragment of 198 bp, the substitution creates a Hinf I recognition sequence which digests the 198 bp fragment into 175 and 23 bp fragments. The region in exon 10 of the factor V gene was amplified the 161 bp amplicon obtained was subjected to Mnl1 digestion, which produced frag-ments of 43 and 118 bp. A 345-bp fragment from exon 14 and the 3'-UT region of the prothrombin gene was amplified. A new Hind lll site (-A/AGCTT-) was introduced in the amplified fragments from the less-frequent allele (A 2 :AAG) yielding two fragments (322 bp and 23 pb in length) after enzyme digestion. The more frequent allele (A 1 :GAG) lacks the restriction site and therefore generates only a 345-bp fragment by PCRHindlll digestion.
Analyses were performed using SPSS (Statistics Package for Social Science). Comparison of categorical data was done by chi-square test, including odds ratios (OR) and 95% confidence interval (CI), t-student test was used to compare age mean between the groups and p values ≤0.05 were considered significant.
RESULTS
Ninety four children (48 boys and 46 girls) were included, with a mean age of 6.6 years (range from 3.2 to 15 years), 24 (13 boys and 11 girls) patients with cerebrovascular involvement were participating in regular blood transfusion program, and 70 (35 boys and 35 girls) patients with normal transcranial Doppler and no CVD. The mean age of children at the time of the diagnosis of CVD was 5.1 years (±SD 1.4 years) and of 5.4 years (±SD 1.6 years) for the control group (p=0.53).
The frequency of α-thalassemia (-α 3.7kb ) in the group with cerebrovascular disease was of 15.8% (3/19) compared to 22.4% (15/67) in the controls (p=0.751).
Table shows molecular characteristics of children according to the presence of CVD. In eight patients, α-chain fragment was not amplified, and in four out of these eight, the β S -globin haplotype could not be genotyped, probably due to DNA quality.
The number of children with CVD was higher (χ 2 =16.8 and p=0.001) among those with Bantu/Atypical than the ones with Bantu/Bantu and Bantu/Benin haplotypes (Table) . Children with Bantu/Atypical haplotype presented 15 times more chance (OR=15.4 [CI 95% 2.9-81.6]) of cerebrovascular involvement than the other β S -globin gene haplotypes (Table) . The C677T polymorphism of MTHFR gene was found in 37.5% (9/24) of children with CVD and in 20% (14/70) of the control group (χ 2 =2.9 and p=0.085). This polymorphism was found in 23% of patients (23/94) and, four children were homozygous for the mutation, while 15 were heterozygous. None of the four homozygous children presented cerebrovascular involvement. No mutation in the FV Leiden or PT genes was found.
DISCUSSION
Stroke is a catastrophic event and represents the second (~10%) leading cause of death in both adult and children 4 . During the last decades, several attempts have been made to detect genetic modifiers of the clinical course in SCA 1,2 , as well as genetic polymorphisms implicated in the occurrence of cerebrovascular disease. Despite all the effort, very few genes have been related to the clinical course of SCA. This report represents the first study of genetic factors and CVD in a group of Brazilian SCA patients. 
